Company page

Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc. (Ticker: ALDX) is a public company based in the United States, focused on developing innovative therapies for immune-mediated diseases. The company has a market capitalization of approximately $118.2 million. Aldeyra is dedicated to advancing its pipeline of treatments to address unmet medical needs.